ASX
196 days, 17 hours ago 
VR1
Vection Technologies LTD
$1.6m Distribution Agreement
Vection Technologies secures a $1.6 million distribution agreement with SolidWorld Group to expand its EMEA market presence.

ASX
199 days, 15 hours ago 
VR1
Vection Technologies LTD
Massachusetts General Hospital trials Algho AI
Vection Technologies' Algho AI, a 3D virtual assistant named Katherine, has moved into a full-scale trial at Massachusetts General Hospital, marking a significant step in AI healthcare integration.

ASX
207 days, 16 hours ago 
VR1
Vection Technologies LTD
New Contracts With Nestle and Natuzzi
Vection Technologies secures $0.5 million in new contracts with Natuzzi and Nestlé, expanding its AI and XR solutions across retail, FMCG, and luxury furniture sectors.
Better than expected
 

ASX
212 days, 16 hours ago 
VR1
Vection Technologies LTD
$0.5m Defence Contract Award
Vection Technologies secures a \$0.5 million cybersecurity contract with a long-term customer in the defense sector, bolstering its position in the national security market.

ASX
213 days, 9 hours ago 
VR1
Vection Technologies LTD
Notification of cessation of securities - VR1
Vectron Technologies Ltd. announced the expiry of 32,500,000 options (VR1AN) on December 3, 2024, resulting in no payment of consideration and leaving 0 options of that class outstanding.

ASX
217 days, 7 hours ago 
VR1
Vection Technologies LTD
Cleansing Notice
Vection Technologies Ltd issued 23,891,876 shares to Mr. Jacopo Merli for achieving performance targets, as approved by shareholders, and provided notice under section 708A(5)(e) of the Corporations Act 2001.

ASX
217 days, 7 hours ago 
VR1
Vection Technologies LTD
Application for quotation of securities - VR1
Vection Technologies Ltd. applied for quotation of 23,891,876 ordinary fully paid shares on the ASX on November 29, 2024, issued to compensate for management services rendered.

ASX
217 days, 17 hours ago 
VR1
Vection Technologies LTD
Results of Meeting
Vection Technologies Ltd (ASX:VR1, OTC:VCTNY) announced that all resolutions put to its Annual General Meeting on November 28, 2024, passed overwhelmingly.
Capital raise
 

ASX
221 days, 17 hours ago 
VR1
Vection Technologies LTD
Vection Technologies Company Presentation
Vection Technologies (ASX: VR1) reported a strong start to FY25 with ~$8 million in pro-forma unaudited Q1 revenue, a 32% increase year-on-year, driven by its AI-powered ecosystem and strategic partnerships.
Better than expected
 

ASX
226 days, 16 hours ago 
VR1
Vection Technologies LTD
$0.7M Sale Expands AI Kiosk Portfolio
Vection Technologies announces a $0.7 million agreement with KIOSK Embedded Systems to integrate its AI avatar technology into their kiosk portfolio, expanding its AI-driven solutions.

ASX
228 days, 16 hours ago 
VR1
Vection Technologies LTD
Additional information - $0.5m AI Dell Algho Appliance Sale
Vection Technologies (ASX:VR1) clarifies a previously announced $0.5 million AI software contract, confirming RCM Italia s.r.l. as the final client and highlighting recurring revenue over three years.

ASX
231 days, 15 hours ago 
VR1
Vection Technologies LTD
$0.5m AI Dell Algho Appliance Sale
Vection Technologies announces a $0.5 million AI software contract win, further validating its recent acquisition and showcasing the potential of its AI solutions in the railway industry.
Better than expected
 

ASX
234 days, 10 hours ago 
VR1
Vection Technologies LTD
VR1O - Holding ranges and Top 20 holders
Vection Technologies Ltd's top 20 shareholders hold 90.96% of its 270,000,000 issued shares, with Evolution Capital Pty Ltd holding the largest stake at 12.59%.

ASX
245 days, 16 hours ago 
VR1
Vection Technologies LTD
$1.6m AI Software Licenses Sale
Vection Technologies announces a $1.6 million AI software license sale to Brexia Med, a European healthcare company, through its recently acquired subsidiary, The Digital Box.
Better than expected
 

ASX
249 days, 7 hours ago 
VR1
Vection Technologies LTD
Results of General Meeting
Vection Technologies (ASX:VR1) shareholders overwhelmingly approved all resolutions at their Extraordinary General Meeting, including those related to the acquisition of The Digital Box S.p.A and share issuances.
Capital raise
 

ASX
256 days, 16 hours ago 
VR1
Vection Technologies LTD
Vection unveils AI platform with Dell
Vection Technologies announces a $0.5 million sale of its AI-powered 'Algho' platform to Dell Technologies, marking a significant step in its AI and spatial computing strategy.
Better than expected
 

ASX
267 days, 14 hours ago 
VR1
Vection Technologies LTD
$3.6m XR Software Licenses Distribution Agreement
Vection Technologies has secured a \$3.6 million distribution agreement with Cometa SpA to provide XR software licenses to 500 Italian high schools by the end of fiscal year 2025.
Better than expected
 

ASX
270 days, 6 hours ago 
VR1
Vection Technologies LTD
Annual General Meeting Key Dates
Vection Technologies Ltd (ASX:VR1) announced its Annual General Meeting will be held on or after November 28, 2024, with nominations for directors closing on October 14, 2024.

ASX
276 days, 6 hours ago 
VR1
Vection Technologies LTD
Reinstatement to Quotation
Vection Technologies Limited (VR1) will have its securities trading reinstated on the ASX on October 2, 2024, following the lodgement of its annual report.
Delay expected
 

ASX
276 days, 16 hours ago 
VR1
Vection Technologies LTD
Vection FY24 Results Presentation
Vection Technologies reported strong FY24 results, including 30% year-on-year revenue growth to $34 million and a 34% increase in EBITDA, driven by strategic acquisitions and a focus on AI-powered XR solutions.
Better than expected
 

VR1 
Vection Technologies LTD 
ASX

$1.6m AI Software Licenses Sale

Sentiment:
 Contract Announcement
 31 October 2024 6:15 PM

Vection Technologies announces a $1.6 million AI software license sale to Brexia Med, a European healthcare company, through its recently acquired subsidiary, The Digital Box.

Better than expected
  The $1.6 million contract significantly exceeds Vection's announcement materiality threshold, indicating better-than-expected results. 

Summary
  • Vection Technologies secured a $1.6 million, three-year contract for AI software licenses with Brexia Med, a European healthcare company.
  • The contract involves the licensing of Algho AI, a proprietary AI solution developed by The Digital Box (TDB), which Vection is in the process of acquiring.
  • The deal includes an option for a two-year extension, potentially increasing the total contract value to over $2.5 million.
  • Brexia Med will use Algho AI for patient screening within a new Hub & Spoke healthcare model.
  • The acquisition of TDB is expected to be completed in Q2 FY25.
  • This contract exceeds Vection's announcement materiality threshold of $500,000.
Sentiment

Score: 8

Explanation: The announcement is overwhelmingly positive, showcasing a significant contract win and highlighting the potential of the acquired technology. However, the acquisition is not yet complete, which slightly tempers the overall sentiment.

Positives
  • Significant $1.6 million contract secured, exceeding the company's materiality threshold.
  • Potential for contract extension adding another $1 million in revenue.
  • Successful integration of acquired company's technology into a major healthcare project.
  • Demonstrates the market potential of Algho AI and Vection's acquisition strategy.
  • Long-term revenue stream established through recurring software licenses.
Negatives
  • Acquisition of TDB is not yet complete, creating some uncertainty.
  • Revenue is dependent on the successful implementation and continued use of the software.
Risks
  • The success of the contract depends on the successful implementation and adoption of Algho AI by Brexia Med.
  • The acquisition of TDB may face unforeseen delays or challenges.
  • The healthcare market is highly competitive, and there's no guarantee of future contracts.
Future Outlook

The contract with Brexia Med demonstrates the potential of Algho AI and opens doors to further opportunities in AI integration across the medical industry and beyond. The acquisition of TDB is expected to be completed in Q2 FY25.

Management Comments
  • 'This contract marks a significant milestone in showcasing the power of TDBs AI capabilities.'
  • 'By providing AI-powered solutions, we are helping Brexia Med revolutionise its patient screening processes, creating a more efficient healthcare system.'
  • 'The Algho AI platform is a game changer, demonstrating how AI can transform critical sectors like healthcare.'
Industry Context

This announcement highlights the growing importance of AI in the healthcare sector and Vection's strategic move to leverage this trend through the acquisition of TDB. The success of this contract could position Vection as a key player in the AI-driven healthcare solutions market.

Next Steps
  • Completion of the acquisition of TDB in Q2 FY25.
  • Implementation of Algho AI by Brexia Med.
  • Exploration of further opportunities in AI integration across the medical industry.
Key Dates
  • 29 August 2024: Vection announced the proposed acquisition of The Digital Box (TDB).
  • 1 November 2024: Date of the ASX release announcing the $1.6 million contract.
  • Q2 FY25: Expected completion date for the acquisition of TDB.
Keywords
AI, Healthcare, Software, Licenses, Acquisition, Vection Technologies, The Digital Box, Algho AI, Brexia Med

VR1 
Vection Technologies LTD 
ASX
Sector: Software & Services
 
Filings with Classifications
Better than expected
29 June 2025 7:19 PM

Defence Contract Award
  • The $4.4 million follow-on supply confirms a successful transition from a proof-of-concept pilot to production delivery, indicating strong client satisfaction and product viability.
  • The cumulative revenue from this customer has reached approximately $10 million, demonstrating significant and growing engagement with a top-tier defence contractor.
  • The planned approximately $21 million in additional contracted options for FY26-FY30 signals substantial future revenue potential and long-term partnership with a key client.
Better than expected
22 June 2025 7:26 PM

Contract Signing Announcement
  • The company secured a significant $2.6 million agreement, which substantially exceeds its $500,000 materiality threshold, indicating a strong new contract win.
Better than expected
16 June 2025 6:53 PM

Strategic Partnership Announcement
  • The $520,000 agreement exceeds the company's internal materiality threshold of $500,000, indicating a significant contract.
  • The partnership targets high-growth markets, with agricultural robotics projected to reach $48 billion by 2030 and precision farming $24 billion by 2030.
  • The modular platform architecture allows for cross-sector deployment, expanding the addressable market beyond agriculture.
Better than expected
9 June 2025 8:01 PM

Investor Presentation
  • The company reported a 60% increase in 1H25 revenues year-on-year, indicating strong top-line growth.
  • Recurring revenue grew by an impressive 204% year-on-year, demonstrating a shift towards a more stable and predictable revenue model.
  • Vection achieved positive adjusted EBITDA in 1H25, a significant improvement from a negative EBITDA in the previous fiscal year, signaling enhanced profitability.
Better than expected
9 June 2025 6:37 PM

Product Launch and Strategic Partnership Announcement
  • The launch on AWS Marketplace provides a significant strategic partnership and market reach that is better than a standalone product launch.
  • The initial contracted annual recurring revenue of $400,000 from early implementations indicates strong immediate commercial traction.
  • The solution addresses a large and growing market opportunity, with the global assistive technology market projected to reach $54.9 billion by 2033.
Better than expected
1 June 2025 6:22 PM

Contract Award Announcement
  • The A$1 million defence order exceeds the company's A$500,000 materiality threshold, indicating a significant win.
  • The order reinforces an ongoing relationship with a strategic customer, suggesting strong client satisfaction and potential for repeat business.
  • The client has already indicated additional significant opportunities, pointing to a robust future pipeline.
Better than expected
28 April 2025 7:30 PM

Placement Announcement
  • The company raised more capital than initially targeted, indicating strong investor demand.
Better than expected
27 April 2025 8:02 PM

FY25 Q3 Activity Report
  • The company reported positive operational cash flow, a significant improvement from previous quarters.
  • Recurring revenue increased substantially, indicating a more stable and predictable revenue stream.
  • The company's cash position improved, providing greater financial flexibility.
Capital raise
27 April 2025 7:43 PM

Trading Halt Request
  • Vection Technologies is planning a capital raising.
  • The capital raising is to support the expansion of its AI business.
  • The capital raising is to support the development of new markets.
Better than expected
27 February 2025 9:41 PM

Half Year Results
  • The company's revenue increased by 15% compared to the previous period.
  • The company reduced its total debt by $5.4 million.
  • Earnings per share improved by 63%.
Capital raise
27 February 2025 9:41 PM

Half-year report
  • In FY25 Vection announced the proposed acquisition of The Digital Box ('TDB'), a generative AI specialist, in tandem with a $2m equity raising (ASX: 29 August 2024).
  • On 5 September 2024, the Company issued 200,000,000 of ordinary fully paid shares at $0.10 ($2m placement as per announced of 29 August 2024).
Better than expected
27 February 2025 9:41 PM

Half-year report
  • The company's revenue increased by 14.9% compared to the previous period.
  • The loss after tax decreased by 58.7% compared to the previous period.
  • Underlying EBITDA turned positive, indicating improved operational efficiency.
Better than expected
27 January 2025 4:33 PM

Quarterly Report
  • The company achieved a positive operating net cash flow in a historically weak quarter, which is better than expected.
  • The company's revenue growth of 60% half-on-half is significantly better than previous periods.
  • The increase in recurring revenue to 34% is a positive sign of business model improvement.
Better than expected
21 January 2025 4:22 PM

Sales Announcement
  • The company has exceeded its materiality threshold of $0.5m in revenue with these new sales.
Capital raise
16 January 2025 4:23 PM

Merger Announcement
  • Vection issued approximately 143 million new shares as part of the initial consideration for the acquisition.
  • Up to 52 million further shares may be issued subject to TDB meeting agreed sales, EBITDA, and balance sheet objectives one year post-acquisition.
Better than expected
8 December 2024 5:35 PM

Contract Wins Announcement
  • Vection Technologies secured new contracts exceeding $500,000, surpassing their defined materiality threshold.
Capital raise
28 November 2024 4:19 PM

Annual General Meeting Results
  • Resolution 4 approved the issuance of shares to Mr. Jacopo Merli.
Better than expected
24 November 2024 4:19 PM

Corporate Presentation
  • Q1 FY25 revenue exceeded expectations with a 32% year-on-year increase, driven by strong demand for Vection's AI and XR solutions.
Better than expected
14 November 2024 6:17 PM

Contract Announcement
  • The $0.5 million contract exceeds expectations, demonstrating strong market demand for Vection's AI solutions and validating the strategic acquisition of TDB.
Better than expected
31 October 2024 6:15 PM

Contract Announcement
  • The $1.6 million contract significantly exceeds Vection's announcement materiality threshold, indicating better-than-expected results.
Capital raise
28 October 2024 3:35 AM

Extraordinary General Meeting Results
  • Share issuances related to the TDB acquisition.
  • Issuance of shares to Exchange Capital Advisory Pty Ltd.
  • Issuance of free attaching options.
  • Issuance of broker options.
Better than expected
20 October 2024 6:57 PM

Partnership Announcement
  • The $0.5 million sale of the 'Algho' platform to Dell exceeded expectations, demonstrating strong market demand and the platform's commercial viability.
Better than expected
9 October 2024 8:30 PM

Distribution Agreement Announcement
  • The \$3.6 million deal exceeds the company's materiality threshold of \$500,000, indicating a positive outcome.
Delay expected
1 October 2024 5:02 AM

Trading Update
  • There was a delay in lodging the annual report for the year ended June 30, 2024, which resulted in a suspension of trading.
Capital raise
30 September 2024 6:21 PM

Annual Report
  • A $2 million placement of ordinary shares at $0.10 was issued on September 5, 2024.
  • Up to circa 55 million Vection shares will be issued if TDB achieves sales and EBITDA objectives and balance sheet valuation targets one year post-acquisition.
Worse than expected
30 September 2024 6:21 PM

Annual Report
  • Despite a 30% increase in revenue, Vection Technologies still reported a net loss after tax, indicating that expenses outweighed the revenue growth.
Better than expected
30 September 2024 6:21 PM

Financial Results
  • Vection Technologies exceeded expectations with 30% year-on-year revenue growth and a 34% increase in EBITDA.
Worse than expected
30 September 2024 6:20 PM

Financial Results Correction
  • The revised financial results show a significantly larger loss than initially reported, primarily due to adjustments in revenue recognition, share-based payments, and asset valuations.
Better than expected
30 July 2024 6:25 PM

FY24 Q4 Activity Report and Appendix 4C
  • The company's cash receipts for Q4 FY24 were better than the prior corresponding period, increasing by 15%.
Better than expected
28 April 2024 7:54 PM

Quarterly Report
  • The company's revenue, cash receipts, and contracted revenue all showed significant growth compared to previous periods, indicating better-than-expected performance.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.